The purpose of this study was to compare plasma concentrations of CD31+/CD42b− MPs, CD62E+ MPs, and CD34+ MPs across CAD, acute CV events (non‐ST elevation myocardial infarction (NSTEMI)), and healthy controls. This evidence concerns the gene CD34 and coronary artery disorder.